pulmonari
extrapulmonari
miliari
abscess
liver
splenic
perinephr
psoa
diverticular
pelvi
osteomyel
endocard
prosthet
associ
infect
lymphoma
leukemia
multipl
myeloma
myelodysplast
syndrom
solid
tumor
renal
cell
hepatoma
giant
cell
arter
still
diseas
polyarter
nodosa
takayasu
arter
granulomatosi
polyangi
mix
cryoglobulinemia
lupu
rheumatoid
arthriti
sulfonamid
penicillin
nitrofurantoin
antimalari
antihistamin
antiepilept
barbitur
phenytoin
nsaidsasa
antihypertens
hydralazin
methyldopa
antiarrhythm
quinidin
procainamid
antithyroid
iodid
quinin
illicit
cocain
fever
endocrin
hypothalam
dysfunct
hyperthyroid
pheochromocytoma
adren
insuffici
infect
dental
abscess
q
fever
leptospirosi
psittacosi
tularemia
melioidosi
syphili
gonococcemia
chronic
meningococcemia
whippl
diseas
yersiniosi
brucellosi
hereditari
period
fever
syndrom
famili
mediterranean
fever
pfapa
syndrom
period
fever
aphthou
stomat
aden
period
syndrom
hyperigd
syndrom
syndrom
famili
cold
autoinflammatori
syndrom
alcohol
hepat
hematoma
factiti
fever
fever
unknown
origin
fuo
durat
week
diagnosi
uncertain
day
hospit
three
outpati
visit
nosocomi
patient
diagnosi
uncertain
day
infect
present
incub
admiss
immunedefici
neutropen
day
neutrophil
count
see
p
detail
hivrel
patient
durat
week
outpati
day
inpati
fever
fever
yet
met
definit
fuo
durat
fever
associ
symptom
cough
dyspnea
hemoptysi
chest
pain
diarrhea
abdomin
pain
dysuria
urethr
discharg
hematuria
neck
stiff
headach
rash
palpabl
purpura
exanthem
exposur
food
water
plant
anim
insect
infect
human
secret
weight
loss
night
sweat
travel
histori
sexual
histori
hiv
risk
factor
immun
past
medic
histori
rheumatolog
disord
malign
alcohol
medic
tachycardia
tachypnea
hypotens
fever
hypoxemia
oral
ulcer
lymphadenopathi
nuchal
rigid
respiratori
cardiac
examin
murmur
tempor
arteri
abdomin
examin
hepatosplenomegali
prostat
examin
skin
lesion
morpholog
distribut
tick
bite
mark
joint
examin
lyte
urea
cr
ast
alt
alp
bilirubin
ldh
ck
serum
protein
electrophoresi
urinalysi
esr
crp
ana
ena
rf
anca
cryoglobulin
c
includ
mycobacteria
sputum
gram
stainafbc
urin
c
stool
c
p
serolog
hbv
hcv
hiv
monospot
cmv
igm
endem
fungi
echocardiogram
suspect
endocard
ct
chestabdpelvi
guid
symptom
fdgpet
may
use
identifi
site
inflamm
malign
fuo
ecg
uberculin
skin
test
tissu
eg
bone
marrow
biopsi
import
diagnost
strategi
care
histori
physic
examin
frequent
reassess
diagnosi
despit
detail
workup
mortal
without
diagnosi
suspect
infecti
etiolog
therapi
delay
due
sever
patient
diseas
see
empir
antibiot
p
gener
therapeut
trial
antimicrobi
steroid
discourag
treat
underli
caus
gramposit
fever
toxic
shock
syndrom
staphylococc
scald
skin
syndrom
acut
rheumat
fever
erythema
marginatum
subcutan
nodul
gramneg
purpura
dissemin
gonococc
infect
gramneg
typhi
pseudomona
ecythema
gangrenosum
vibrio
vulnificu
endocard
burgdorferi
lyme
erythema
migran
treponema
pallidum
chancr
secondari
syphili
mountain
spot
fever
ehrlichiosi
typhu
viral
hiv
mononucleosi
rubella
measl
roseola
erythema
infectiosum
chickenpox
shingl
coxsacki
viru
echoviru
coccidioid
histoplasma
dermatomyos
bowel
diseas
reactiv
arthriti
polyangi
polyarter
nodosa
b
ehcet
diseas
leukemia
metastat
paraneoplast
cephalosporin
sulfa
barbitur
phenytoin
procainamid
quinidin
erythema
nodosum
sweet
syndrom
acut
febril
neutrophil
dermatosi
exanthem
scarlet
fever
acut
rheumat
fever
like
children
mononucleosi
common
young
adult
diseas
common
spring
summer
coxsacki
viru
echoviru
common
summer
fall
meningococcu
parvoviru
common
winter
spring
geograph
diseas
pacif
northwest
midwest
northeast
usa
southern
canadian
locat
rmsf
southcentr
atlant
state
ehrlichiosi
midwestern
southcentr
southeastern
state
tularemia
western
southeastern
southcentr
state
canada
relaps
fever
borrelia
hermsii
mountain
area
western
usa
endem
fungal
infect
includ
blastomyc
dermatitidi
southeastern
state
manitoba
ontario
coccidioid
immiti
southwestern
state
histoplasma
capsulatum
mississippi
ohio
river
valley
quebec
durat
fever
associ
symptom
cough
dyspnea
chest
pain
diarrhea
abdomin
pain
dysuria
urethr
discharg
neck
stiff
headach
rash
prodrom
locat
progress
treatment
exposur
food
water
plant
anim
infect
human
secret
weight
loss
night
sweat
travel
histori
sexual
histori
immun
past
medic
histori
rheumatolog
disord
malign
medic
tachycardia
tachypnea
hypotens
fever
hypoxemia
oral
ulcer
lymphadenopathi
nuchal
rigid
respiratori
cardiac
examin
murmur
abdomin
examin
hepatosplenomegali
skin
lesion
morpholog
distribut
tick
bite
eschar
joint
examin
lyte
urea
cr
ast
alt
alp
bilirubin
esr
urinalysi
c
sputum
gram
stainafbc
urin
c
monospot
test
cmv
igm
ebv
hiv
serolog
eg
rickesttsi
serolog
lumbar
suspect
meningococcu
skin
consult
inflammatori
ana
ena
plu
contact
precaut
uncertain
diagnosi
purpura
bacteri
sepsi
institut
droplet
contact
isol
precaut
see
p
detail
treat
underli
caus
transmit
tick
except
q
fever
coxiella
burnetii
associ
rash
myalgia
headach
except
q
fever
ehrlichiosi
involv
degre
vascul
dic
part
pathogenesi
treat
doxycyclin
r
ocki
ountain
spot
rickettsii
transmit
tick
common
midatlant
state
macularmaculopapular
rash
begin
extrem
move
central
involv
palmssol
treat
doxycyclin
murin
vector
rash
begin
central
move
peripher
treat
doxycyclin
chloramphenicol
chaffeensi
human
monocyt
ehrlichiosi
transmit
lone
star
tick
peak
may
juli
infect
lymphocyt
monocyt
neutrophil
intracellularli
fever
headach
myalgia
leukopenia
thrombocytopenia
elev
transaminas
maculopapular
petechi
rash
human
granulocyt
anaplasmosi
caus
relat
ehrlichia
produc
similar
ill
without
rash
transmit
ixod
tick
coinfect
lyme
diseas
possibl
treat
doxycyclin
q
burnetii
transmit
respiratori
spread
infect
anim
bodi
fluid
eg
cattl
sheep
goat
cat
rash
fever
pneumon
hepat
endocard
cn
symptom
treat
doxycyclin
burgdorferi
transmit
tick
bite
attach
h
think
concomit
tick
born
diseas
clinic
common
tickborn
diseas
usa
particularli
coastal
atlant
state
california
spring
summer
stage
earli
day
erythema
migran
fever
meningismu
lymphadenopathi
stage
dissemin
month
hematogen
spread
neurolog
symptom
facial
nerv
palsi
lymphocyt
mening
enceph
chorea
myeliti
radicul
peripher
neuropathi
carditi
av
block
dilat
cardiomyopathi
may
multipl
skin
lesion
erythema
migran
stage
late
year
mono
oligoarthr
acrodermat
chronica
atrophican
europ
progress
enceph
dementia
amen
antibiot
therapymay
develop
postlym
syndrom
musculoskelet
pain
neurocognit
symptom
dysesthesia
fatigu
amen
antibiot
therapi
antib
burgdorferi
elisa
posit
confirm
western
blot
cloth
tick
repel
tick
bite
h
hyperendem
area
consid
doxycyclin
mg
dose
within
h
tick
bite
doxycyclin
mg
po
bid
day
cefuroxim
mg
po
bid
day
lyme
carditi
ceftriaxon
g
iv
day
third
degre
av
block
otherwis
stage
oral
antibiot
neurolog
lyme
ceftriaxon
g
iv
day
lyme
arthriti
doxycyclin
mg
bid
day
amoxicillin
j
erxheim
patient
may
experi
transient
worsen
symptom
first
h
treatment
result
host
immun
respons
antigen
releas
die
organ
typic
lyme
syphili
caus
fever
chill
myalgia
exacerb
rash
singl
compon
histori
physic
examin
emerg
one
make
diagnosi
erythema
migran
highli
like
sign
symptom
examin
combin
laboratori
test
limit
util
endem
area
combin
histori
tick
bite
solitari
lesion
appropri
size
morpholog
presenc
system
symptom
consist
erythema
migran
nonendem
area
factor
also
suggest
diagnosi
prompt
investig
jama
microti
usa
b
divergen
europ
transmit
ixod
tick
also
transmit
lyme
diseas
ehrlichia
fever
chill
sweat
malais
myalgia
arthralgia
headach
day
particularli
immunosuppress
individu
clinic
southern
new
england
southern
new
york
wisconsin
minnesota
smear
maltes
cross
format
seen
malaria
pcr
serolog
plu
azithromycin
exanthemat
lesion
p
see
joint
pain
fever
p
see
sepsi
p
gram
aureu
coagulaseneg
staphylococci
streptococcu
pneumonia
corynebacterium
gram
escherichia
coli
klebsiella
pneumonia
pseudomona
c
difficil
anaerob
tb
vzv
cmv
ebv
enteroviru
rsv
influenza
respiratori
virus
aspergillu
cryptococcu
fusarium
coccidioid
toxoplasma
tuberculosi
temp
h
anc
expect
nadir
band
injuri
mucos
barrier
immun
defect
due
drug
underli
diseas
invas
devic
attenu
immun
respons
patient
may
rel
asymptomat
decompens
due
overwhelm
infect
fever
sometim
warn
sign
alway
taken
serious
patient
risk
develop
neutropenia
commonli
idiopath
bacteri
sourc
identifi
approxim
episod
usual
patient
endogen
flora
fungal
infect
replac
bacteri
infect
promin
day
fever
usual
abat
return
neutrophil
fever
persist
return
neutropenia
resolv
consid
hepatosplen
candidiasi
usual
asymptomat
fever
determin
sever
durat
fever
associ
sign
symptom
cough
dyspnea
chest
pain
diarrhea
abdomin
pain
dysuria
urethr
discharg
neck
stiff
headach
rash
recent
chemotherapi
nadir
neutrophil
count
usual
day
posttreat
weight
loss
night
sweat
travel
histori
sexual
histori
immun
past
medic
histori
malign
rheumatolog
disord
medic
chemotherapi
gcsf
tachycardia
tachypnea
hypotens
fever
hypoxemia
oral
ulcer
lymphadenopathi
nuchal
rigid
respiratori
cardiac
examin
murmur
abdomin
examin
hepatosplenomegali
skin
lesion
morpholog
distribut
import
site
examin
includ
venou
access
devic
sinus
perian
region
abscess
digit
rectal
examin
recommend
potenti
rectal
tear
transloc
gut
microb
also
avoid
rectal
thermomet
enema
suppositori
lyte
urea
cr
ast
alt
alp
bilirubin
urinalysi
c
cultur
peripher
blood
addit
central
line
port
sputum
gram
stainafbc
urin
c
stool
c
p
c
difficil
toxin
diarrhea
sinu
xray
anc
peak
temperatur
signific
symptom
sign
signific
comorbid
nearli
normal
renal
hepat
function
neutropenia
day
dehydr
hypotens
age
year
mg
po
bid
mg
po
may
send
home
followup
anticip
prolong
day
durat
profound
neutropenia
anc
andor
signific
medic
comorbid
condit
hypotens
pneumonia
newonset
abdomin
pain
neurolog
chang
intraven
antibiot
first
imipenem
mg
iv
meropenem
g
iv
ceftazidim
g
iv
cefepim
g
iv
piperacillintazobactam
g
iv
piperacillin
g
iv
plu
tobramycin
mgkg
iv
clindamycin
mg
iv
plu
tobramycin
mgkg
iv
piperacillintazobactam
g
iv
plu
gentamicin
mgkg
iv
second
vancomycin
g
iv
suspect
line
infect
known
colon
mrsa
gramposit
blood
cultur
hypotens
third
antifung
febril
day
hemodynam
unstabl
fluconazol
mg
iv
daili
itraconazol
mg
iv
daili
amphotericin
b
mgkg
iv
daili
h
caspofungin
mg
first
day
follow
mg
iv
daili
unexplain
persist
fever
patient
whose
condit
otherwis
stabl
rare
requir
empir
chang
initi
antibiot
regimen
infect
identifi
antibiot
adjust
accordingli
treatment
issu
patient
bacteremiacandidemia
organ
coagulaseneg
staphylococci
patient
becom
afebril
day
known
specif
antibiot
unknown
etiolog
low
ciprofloxacin
plu
afebril
h
unknown
etiolog
high
antibiot
persist
fever
first
day
clinic
stabl
day
antibiot
stop
vancomycin
cultur
neg
progress
diseas
day
antibiot
febril
day
antifung
afebril
day
stop
anc
consecut
day
afebril
h
cultur
neg
obviou
sign
infect
anc
day
afebril
day
patient
initi
low
risk
subsequ
complic
continu
criteria
met
persist
fever
day
stop
anc
consecut
day
continu
anc
reassess
continu
antibiot
week
consid
stop
therapi
diseas
site
found
condit
stabl
mg
iv
acetaminophen
tab
po
hydrocortison
mg
iv
min
dose
repeat
h
administr
primari
recommend
prevent
febril
neutropenia
highrisk
age
medic
histori
poor
perform
statu
previou
febril
neutropenia
extens
prior
treatment
poor
nutrit
open
wound
activ
infect
diseas
characterist
bone
marrow
involv
myelotox
chemotherapi
regimen
chemoradi
chemotherapi
higher
risk
febril
neutropenia
dose
dens
regimen
secondari
recommend
patient
experienc
neutropen
complic
prior
cycl
chemotherapi
primari
prophylaxi
receiv
reduc
dose
may
compromis
diseasefre
surviv
overal
surviv
treatment
outcom
treatment
patient
febril
given
high
risk
develop
complic
includ
expect
prolong
day
profound
neutropenia
age
year
uncontrol
primari
diseas
pneumonia
hypotens
multiorgan
dysfunct
sepsi
invas
fungal
infect
hospit
time
develop
fever
special
situat
stem
cell
mobil
peripher
blood
progenitor
cell
often
conjunct
chemotherapi
also
administ
autolog
allogen
stem
cell
transplant
gcsf
given
patient
diffus
aggress
lymphoma
age
older
treat
cur
chemotherapi
chop
aggress
regimen
given
shortli
complet
initi
induct
chemotherapi
modestli
decreas
durat
neutropenia
complet
initi
first
day
chemotherapi
initi
induct
first
postremiss
cours
thu
shorten
durat
neutropenia
approxim
week
use
increas
anc
neutropen
patient
intermitt
administr
csf
may
consid
subset
patient
sever
neutropenia
recurr
infect
given
patient
expos
lethal
dose
total
bodi
radiotherapi
dose
high
enough
lead
certain
death
due
injuri
organ
j
clin
oncol
injuri
patient
profound
neutropenia
impair
host
defens
necrosi
bowel
wall
involv
cecum
extend
ascend
colon
termin
ileum
clinic
pain
especi
rlq
neutropen
patient
abd
avoid
barium
enema
colonoscopi
rest
ng
suction
iv
fluid
nutrit
support
broad
spectrum
antibiot
gcsf
surgic
indic
includ
periton
perfor
persist
gi
bleed
clinic
deterior
chemotherapi
p
neutropenia
p
sepsi
p
stem
cell
transplant
p
typhoid
fever
rickettsi
leptospirosi
enceph
west
nile
enceph
tickborn
enceph
poliomyel
rabi
angiostrongyliasi
trypanosomiasi
pneumonia
mycoplasma
legionella
q
fever
typhoid
fever
scrub
typhu
parainfluenza
metapneumoviru
respiratori
syncyti
viru
adenoviru
dengu
coronaviru
coccidioidomycosi
loeffler
syndrom
migrat
larval
helminth
ascari
strongyloid
hookworm
fever
rash
p
meningococcemia
leptospirosi
yellow
fever
ebola
fever
lassa
fever
marburg
cmv
ebv
hiv
hbv
acut
hookworm
ascari
strongyloid
acut
schistosomiasi
viscer
larva
migran
lymphat
filariasi
acut
trichinosi
typhoid
fever
dengu
shock
syndrom
ehrlichiosi
rocki
mountain
spot
fever
enteroaggreg
e
coli
campylobact
jejuni
salmonella
shigella
vibrio
aeromona
plesiomona
c
difficil
norwalk
norwalklik
rotavirus
ebola
fever
enterovirus
lamblia
cryptosporidium
parvum
entamoeba
histolytica
cyclospora
cayetanensi
isospora
belli
e
polecki
balantidium
coli
trichinella
spirali
enteropathogen
e
coli
c
jejuni
shigella
salmonella
yersinia
enterocolitica
aeromona
plesiomona
c
difficil
tropheryma
whippelii
avium
complex
brasiliensi
histoplasma
capsulatum
lamblia
e
histolytica
cryptosporidium
parvum
c
cayetanensi
trichuri
trichiura
strongyloid
stercorali
schistosomiasi
capillaria
philippinensi
fasciolopsi
buski
metagonimu
yokogawai
echinostoma
overgrowth
syndrom
disaccharidas
defici
tropic
sprue
irrit
bowel
syndrom
inflammatori
bowel
diseas
cancer
lax
use
endocrinopathi
dysmotil
idiopath
durat
fever
associ
symptom
cough
dyspnea
chest
pain
diarrhea
abdomin
pain
dysuria
urethr
discharg
neck
stiff
headach
weight
loss
night
sweat
travel
histori
specif
itinerari
activ
exposur
includ
food
freshsaltwat
histori
incub
period
sexual
histori
immun
statu
antimalari
chemoprophylaxi
medic
degre
adher
past
medic
histori
rheumatolog
disord
malign
medic
tachycardia
tachypnea
hypotens
fever
hypoxemia
oral
ulcer
lymphadenopathi
nuchal
rigid
respiratori
cardiac
examin
murmur
abdomin
examin
hepatosplenomegali
skin
lesion
morpholog
distribut
tick
bite
mark
joint
examin
lyte
urea
cr
ast
alt
alp
bilirubin
urinalysi
c
sputum
gram
stainafbc
urin
c
stool
c
p
c
diff
toxin
ab
malaria
thick
thin
smear
repeat
within
h
initi
neg
result
serolog
hiv
dengu
rickettsia
schistosomiasi
strongyloidiasi
leptospira
hav
hbv
hcv
hepat
e
us
abd
guid
symptom
lumbar
punctur
regardless
travel
influenza
pneumococc
age
hepat
b
mmr
dpt
develop
countri
hepat
specif
countri
meningococc
japanes
enceph
yellow
fever
highrisk
activ
rabi
outbreak
cholera
imodium
diarrhea
develop
ill
potenti
fatal
may
public
health
threat
typhoid
fever
dengu
fever
diarrheal
diseas
respiratori
infect
lyme
diseas
q
fever
brucellosi
import
caus
fever
return
travel
p
falciparum
rapidli
fatal
must
rule
febril
travel
return
malariaendem
region
shortest
incub
period
affect
travel
becom
ill
within
day
return
mosquito
bite
transmit
sporozoit
travel
liver
invad
hepatocyt
divid
form
schizont
contain
merozoit
asymptomat
ruptur
day
releas
merozoit
bloodstream
infect
erythrocyt
matur
ring
form
trophozoit
matur
schizont
asexu
form
p
vivax
p
oval
p
falciparum
p
malaria
hour
merozoit
releas
erythrocyt
fever
anemia
lactic
acidosi
cytokin
releas
infect
new
red
cell
merozoit
differenti
male
femal
gametocyt
sexual
form
circul
blood
ingest
mosquito
p
vivax
p
oval
may
stay
dormant
liver
hypnozoit
may
caus
late
relaps
reactiv
mani
month
contrast
p
falciparum
p
malaria
liver
stage
caus
relaps
p
falciparum
specif
induc
obstruct
microvascular
blood
flow
may
lead
organ
dysfunct
eg
cerebr
malaria
renal
failur
ard
hypoglycemia
anemia
dic
gastroenter
clinic
falciparum
acquir
mostli
subsaharan
africa
p
vivax
mostli
asia
latin
america
symptom
includ
spike
fever
chill
headach
back
pain
cough
gi
problem
splenomegali
thrombocytopenia
without
leukocytosi
may
present
cerebr
malaria
p
falciparum
present
alter
level
conscious
seizur
univers
fatal
untreat
thin
smear
need
repeat
h
rule
malaria
rel
risk
contract
malaria
vari
geograph
region
caribbean
north
africa
south
america
southeast
asia
central
america
south
asia
oceania
subsaharan
africa
travel
advis
wear
long
sleevesp
dusk
dawn
use
mosquito
repel
contain
deet
consid
permethrintr
mosquito
net
chloroquin
may
use
travel
destin
chloroquinesensit
p
falciparum
eg
central
america
part
middl
east
destin
chloroquineresist
p
falciparum
present
chemoprophylaxi
mefloquin
doxycyclin
use
give
doxycyclin
travel
destin
p
falciparum
resist
chloroquin
mefloquin
sulfonamid
eg
region
thailand
cambodia
china
lao
vietnam
associ
fewest
side
effect
mefloquin
eas
weekli
dose
doxycyclin
cheapest
requir
prolong
cours
caus
sun
sensit
cdc
risk
assess
prophylaxi
recommend
avail
onlin
http
emerg
treatment
choic
complic
malaria
option
includ
mefloquin
nonfalciparum
nejm
exposur
food
water
contamin
salmonella
typhi
clinic
develop
countri
fever
chill
headach
myalgia
abdomin
pain
constip
uncommonli
diarrhea
rel
bradycardia
splenomegali
rose
spot
faint
salmoncolor
macul
abdomen
trunk
septic
symptom
intestin
perfor
may
occur
second
week
stool
urin
bone
marrow
highest
sensit
cultur
cbc
may
show
leukopenia
ceftriaxon
azithromycin
transmit
mosquito
flulik
ill
day
later
may
develop
lymphadenopathi
maculopapularpetechi
rash
dengu
shock
syndrom
dengu
hemorrhag
fever
previous
expos
serotyp
clinic
mostli
tropic
subtrop
area
fever
headach
retroorbit
pain
sever
myalgiaarthralgia
leukopenia
thrombocytopenia
possibl
transmit
fruit
bat
person
person
transmiss
occur
direct
contact
blood
bodili
fluid
saliva
blood
vomit
stool
semen
infect
symptomat
patient
incub
period
day
outbreak
sierra
leon
guinea
liberia
clinic
symptom
includ
fever
headach
myalgiaarthralgia
vomit
diarrhea
abdomin
pain
conjunctiv
inject
rash
late
symptom
includ
bleed
shock
delirium
death
index
suspicion
patient
recent
endem
area
ebola
outbreak
serolog
sen
rtpcr
sen
close
spc
isol
support
measur
mainstay
experiment
therapi
zmapp
consist
monoclon
antibodi
ebola
viral
antigen
efficaci
proven
viral
infect
acquir
africa
asia
larg
outbreak
ongo
indian
ocean
island
india
clinic
usual
within
day
exposur
sever
joint
pain
involv
small
joint
hand
wrist
ankl
may
prolong
leukopenia
thrombocytopenia
elev
transaminas
may
seen
acut
convalesc
nsaid
tick
typhu
rickettsia
africa
mediterranean
tick
typhu
r
conorii
scrub
typhu
orientia
tsutsugamushi
transmit
tick
clinic
bite
inocul
eschar
triad
fever
headach
myalgia
rash
may
present
lymphadenopathi
leukopenia
thrombocytopenia
interrogan
zoonosi
common
tropic
area
clinic
exposur
freshwat
fever
headach
myalgia
rash
conjunctiv
suffus
may
associ
asept
mening
uveiti
elev
transaminas
jaundic
proteinuria
microscop
hematuria
fulmin
syndrom
jaundic
renal
failur
hemorrhag
weil
diseas
cultur
blood
urin
csf
amoxicillin
mild
diseas
penicillinampicillin
ceftriaxonecefotaxim
iv
sever
diseas
facult
intracellular
coccobacilli
clinic
drink
eat
infect
anim
product
milk
inhal
direct
anim
contact
skin
wound
fever
may
involv
organ
system
particularli
joint
sacroili
gu
epididymoorch
cn
mening
eye
uveiti
cardiac
endocard
pulmonari
pneumon
pleural
effus
empyema
caus
abscess
hepat
splenic
thyroid
epidur
may
develop
chronic
hepatosplen
diseas
cultur
serolog
plu
streptomycin
rifampin
nejm
worm
haematobium
mansoni
intercalatum
subsaharan
africa
mansoni
part
south
america
japonicum
asia
mekongi
cambodia
freshwat
exposur
cercaria
penetr
skin
larva
migrat
lung
venou
circul
migrat
heart
migrat
liver
matur
pair
migrat
mesenter
venul
bowel
mansoni
mekongi
japonicum
intercalatum
bladder
hematobium
femal
lay
egg
excret
fece
urin
matur
cercaria
clinic
parasit
infect
gener
seen
patient
endem
area
instead
travel
initi
penetr
skin
may
caus
pruritu
acut
schistosomiasi
katayama
fever
includ
fever
headach
myalgia
ruq
pain
bloodi
diarrhea
dyspnea
chronic
schistosomiasi
granuloma
format
due
host
immun
respons
schistosom
egg
lead
hepat
cirrhosi
intestin
diarrhea
occult
blood
fibrosi
genitourinari
tract
symptom
hematuria
dysuria
calcif
fibrosi
rare
cn
seizur
focal
deficit
transvers
myeliti
involv
schistosom
egg
fece
urin
biopsi
rectum
bladder
mgkg
po
dose
dose
japonicum
mekongi
adjunct
corticosteroid
katyama
fever
see
pneumonia
p
see
endocard
p
malign
syndrom
serotonin
syndrom
sympathomimet
alcohol
withdraw
infecti
pneumonia
n
meningitidi
h
influenza
l
monocytogen
klebsiella
e
coli
serratia
pseudomona
viral
enteroviru
vzv
influenza
mump
hiv
tb
fungal
cryptococcu
west
nile
st
loui
equin
la
cross
storm
structur
epidur
subdur
intracerebr
cerebr
infarct
tumor
pituitari
apoplexi
lupu
vascul
granulomat
angiiti
age
agalactia
e
coli
listeria
monocytogen
k
pneumonia
age
agalactia
e
coli
pneumonia
h
influenza
n
meningitidi
age
pneumonia
n
meningitidi
age
pneumonia
n
meningitidi
l
monocytogen
aerob
gramneg
bacilli
aerob
gram
neg
bacilli
neurosurgeryhead
aureu
epidermidi
aerob
gramneg
bacilli
csf
aureu
epidermidi
aerob
gram
neg
bacilli
diphtheroid
basilar
skull
pneumonia
h
influenza
group
streptococci
aerob
gramneg
bacilli
includ
klebsiella
e
coli
serratia
pseudomona
otiti
media
mastoid
sinus
endocard
head
trauma
csf
leak
alcohol
splenectomi
age
alcohol
malign
immunosuppress
diabet
hepat
failur
renal
failur
iron
overload
collagen
vascular
diseas
hiv
complic
includ
herniat
stroke
vascul
acut
cerebr
hemorrhag
aneurysm
format
cerebr
vessel
symptom
seizur
hear
loss
neuropsycholog
impair
system
complic
includ
septic
shock
pneumonia
ard
find
suffici
accur
diagnos
mening
absenc
sign
classic
triad
fever
neck
stiff
alter
mental
statu
suffici
sensit
rule
diagnosi
mening
fever
neck
stiff
sensit
find
triad
kernig
brudzinski
sign
low
sensit
high
specif
jolt
accentu
headach
may
use
adjunct
maneuv
patient
fever
headach
requir
valid
jama
ration
clinic
examin
mcgrawhil
lyte
crurea
inr
ptt
ast
alt
alp
bilirubin
fibrinogen
urinalysi
c
sputum
gram
stainafbc
urin
c
head
ct
see
lumbar
cell
count
differenti
gram
stain
c
afb
cell
count
differenti
protein
glucos
lactat
pcr
hsv
vzv
enterovirus
cytolog
bacteri
infect
high
neutrophil
low
glucos
high
protein
posit
cultur
suspect
viral
infect
high
lymphocyt
normal
glucos
normalhigh
protein
nejm
open
caus
elev
open
pressur
includ
mening
pseudotumor
cerebri
intracrani
hemorrhag
tumor
idiopath
cell
count
wbc
increas
bacteri
mening
neutrophil
mainli
viral
mening
lymphocyt
predomin
caus
includ
seizur
intracerebr
hemorrhag
tumor
traumat
tap
correct
wbc
everi
rbc
rbc
present
patient
within
h
subarachnoid
hemorrhag
onset
gram
untreat
bacteri
mening
partial
treat
case
standard
sensit
untreat
bacteri
mening
partial
treat
case
viral
tb
fungal
cultur
may
done
well
gl
significantli
elev
bacteri
mening
obstruct
variabl
elev
fungal
tb
infect
sometim
elev
viral
infect
caus
includ
tumor
intracrani
hemorrhag
multipl
sclerosi
syndrom
serum
level
mm
mgdl
significantli
lower
bacteri
mening
mildli
lower
fungal
tb
infect
usual
normal
viral
infect
use
atraumat
needl
compar
standard
needl
use
standard
needl
compar
standard
needl
shown
associ
reduc
risk
headach
lumbar
punctur
reinsert
stylet
needl
remov
occur
arr
patient
requir
bed
rest
procedur
jama
lumbar
punctur
age
immunocompromis
histori
cn
diseas
seizur
within
week
focal
neurolog
abnorm
papilloedema
obtund
unconsci
inabl
answer
two
question
correctli
inabl
follow
two
command
correctli
nejm
rate
pneumonia
mening
n
meningitidi
mening
factor
confer
poor
prognosi
includ
system
compromis
level
conscious
pneumonia
nejm
iv
intub
droplet
precaut
suspect
n
meningitidi
infect
acut
bacteri
mening
min
first
dose
antibiot
dexamethason
mgkg
mg
iv
day
cefotaxim
g
iv
ceftriaxon
g
iv
add
vancomycin
mg
iv
concern
penicillinresist
pneumococci
add
ampicillin
g
iv
age
listeria
coverag
neurosurgerytrauma
csf
shunt
basilar
skull
fractur
give
ceftazidim
g
iv
plu
vancomycin
hsv
enceph
give
acyclovir
mgkg
iv
pneumonia
penicillin
g
ampicillin
mic
ceftriaxon
cefotaxim
vancomycin
day
mic
n
meningitidi
ceftriaxon
penicillin
g
ampicillin
day
l
monocytogen
ampicillin
penicillin
g
plu
gentamicin
day
h
influenza
ampicillin
ceftriaxon
cefotaxim
day
enterobacteriacea
ceftriaxon
cefotaxim
day
week
symptom
persist
csf
abnorm
tb
fungal
infect
neurosarcoidosi
lymphoma
leptomening
carcinomatosi
predisposit
myelomeningocel
dermal
sinu
acquir
trauma
tumor
shunt
immunolog
defect
complement
defect
antibodi
defect
splenectomi
infect
tempor
lobe
subacut
ill
fever
focal
neurolog
abnorm
aphasia
mental
statu
chang
seizur
may
longterm
sequela
punctur
mild
lymphocyt
pleocytosi
erythrocyt
xanthochromia
protein
normal
glucos
pcr
mri
hyperintens
lesion
inferior
medial
tempor
lobe
often
extend
insula
mgkgdose
day
west
nile
viru
transmit
mosquito
late
spring
earli
autumn
clinic
spectrum
asymptomat
sever
neurolog
disord
fever
erythemat
rash
mening
enceph
flaccid
paralysi
risk
progress
sever
neurolog
diseas
highest
elderli
punctur
viral
pictur
pcr
west
nile
viru
igm
antibodi
west
nile
viru
serum
cerebrospin
fluid
sampl
acut
convalesc
phase
submit
least
week
apart
prevent
key
insect
repel
proper
cloth
delirium
p
infect
control
p
sexual
transmit
trachomati
neisseria
gonorrhoea
hsv
urinari
tract
infect
urethr
cystiti
pyelonephr
perinephr
abscess
k
lebsiella
e
coli
e
nterococci
p
roteu
taphylococcu
saprophyticu
vagin
albican
trichomona
bacteri
vaginosi
function
anatom
abnorm
urinari
tract
polycyst
kidney
diseas
nephrolithiasi
neurogen
bladder
diabet
immunosuppress
pregnanc
indwel
urinari
cathet
recent
urinari
tract
instrument
risk
factor
women
uncompl
uti
usual
treat
day
day
nitrofurantoin
women
fever
costovertebr
angl
tender
blood
urin
cultur
indic
challeng
differenti
cystiti
pyelonephr
young
recent
sexual
activ
elderli
estrogen
defici
incontin
diabet
cystocel
previou
gu
surgeri
establish
biofilm
cathet
enter
bladder
intra
extralumin
common
organ
includ
e
coli
enterococci
respons
urosepsi
risk
factor
includ
durat
catheter
error
cathet
care
diabet
mellitu
femal
sex
four
symptom
dysuria
frequenc
hematuria
back
pain
one
sign
cva
tender
increas
probabl
uti
may
effect
rule
present
howev
combin
reliabl
rule
uti
urinalysi
moder
power
consid
women
appropri
urinari
tract
symptom
dipstick
leukocyt
esteras
nitrit
posit
probabl
uti
high
especi
combin
posit
find
histori
physic
dipstick
neg
probabl
diseas
still
rel
high
urin
cultur
consid
rule
infect
jama
ration
clinic
examin
mcgrawhil
lyte
crurea
urinalysi
c
bacteria
clean
catch
suggest
uti
sen
use
lower
threshold
women
symptom
sensit
increas
specif
decreas
slightli
leukocyt
esteras
sen
spc
pyuria
sen
spc
bacteria
sen
spc
necessari
symptomat
uncompl
uti
alway
need
symptomat
biochem
evid
ie
leukocyt
esteras
uncompl
uti
see
clinic
featur
howev
antimicrobi
resist
increas
cultur
sensit
may
becom
import
mg
tab
po
bid
day
ciprofloxacin
mg
po
bid
day
levofloxacin
mg
po
daili
day
nitrofurantoin
macrocryst
mg
po
qid
day
nitrofurantoin
monohydr
macrocryst
mg
po
bid
day
mg
po
bid
day
fosfomycin
trometamol
g
po
dose
durat
day
consid
measur
episod
utiyear
lowdos
prophylaxi
ds
tab
po
qh
month
nitrofurantoin
mg
macrocryst
mg
po
qh
month
postcoit
prophylaxi
ds
tab
po
postcoit
nitrofurantoin
mg
po
macrocryst
mg
po
postcoit
patientiniti
treatment
start
standard
dose
antibiot
onset
uti
symptom
mg
po
tid
day
empirc
oral
fluoroquinolon
ciprofloxacin
mg
po
bid
levofloxacin
mg
po
daili
isol
suscept
may
treat
amoxicillin
otherwis
healthi
nonpregn
women
pyelonephr
treat
outpati
basi
otherwis
treat
iv
antibiot
least
initi
aminoglycosid
ampicillin
third
gener
cephalosporin
carbapenem
replac
cathet
initi
antibiot
symptomat
infect
switch
intermitt
catheter
pregnant
women
week
treat
bacteriuria
amoxicillin
nitrofurantoin
day
even
asymptomat
risk
pyelonephr
avoid
fluoroquinolon
cheesi
vagin
discharg
intens
itch
diagnosi
microscopi
koh
show
hypha
bud
yeast
ph
normal
treat
vagin
antifung
cream
day
fluconazol
mg
po
dose
purul
greenish
vagin
discharg
strawberri
cervix
diagnosi
microscopi
show
motil
trichomonad
ph
treat
oral
metronidazol
g
singl
dose
treatment
sexual
partner
indic
fishysmel
vagin
discharg
diagnosi
made
amin
odor
koh
ad
discharg
ph
clue
cell
vagin
epitheli
cell
coat
bacteria
seen
microscopi
treat
symptomat
pregnant
metronidazol
clindamycin
oral
vagin
gonorrhea
chlamydia
trachomati
nongonococc
ureaplasma
urealyticum
mycoplasma
genitalium
trichomona
vaginali
hsv
stain
discharg
urin
chlamydiagonorrhea
nucleic
acid
amplif
test
naat
urethralcerv
swab
gonorrhea
cultur
offer
syphili
hiv
test
cefixim
mg
po
ceftriaxon
mg
im
plu
azithromycin
g
po
antichlamydi
azithromycin
g
po
doxycyclin
mg
po
bid
day
gonorrhea
identifi
empir
treat
gonococcu
chlamydia
sinc
dual
infect
common
dual
therapi
recommend
gonorrhea
due
increas
incid
resist
third
gener
cephalosporin
trace
treat
partner
within
last
day
pallidum
infect
risk
factor
includ
men
sex
men
msm
sex
trade
hiv
infect
primari
chancr
painless
indur
nonpurul
ulcer
within
day
secondari
within
week
month
symptom
fever
maculopapular
rash
mucocutan
lesion
alopecia
lymphadenopathi
mening
uveiti
cranial
neuriti
tertiari
year
may
involv
heart
aortiti
eye
iriti
argyl
robertson
pupil
bonessoft
tissu
gumma
neurolog
system
gener
paresi
rapidli
progress
dementia
psychot
featur
tabe
dorsali
affect
posterior
column
spinal
cord
dorsal
root
lead
pain
episod
decreas
vibrat
propriocept
absent
reflex
bowelbladd
dysfunct
diagnost
test
choic
primari
syphilit
chancr
either
dfa
pcr
avail
otherwis
treponem
serolog
sensit
becom
posit
earlier
nontreponem
serolog
would
prefer
primari
syphili
consider
primari
secondari
earli
latent
year
syphili
benzathin
penicillin
g
unit
im
prefer
doxycyclin
mg
po
bid
week
late
latent
year
syphili
gummat
cardiovascular
syphili
benzathin
penicillin
g
unit
im
week
neurosyphili
syphilit
eye
diseas
give
benzathin
penicillin
g
unit
iv
day
followup
essenti
treatment
failur
defin
persist
symptom
failur
serolog
test
declin
fold
within
month
endometr
tuboovarian
abscess
salping
pelvic
periton
commonli
due
n
gonorrhoea
c
trachomati
homini
u
urealyticum
may
involv
endogen
gut
organ
includ
anaerob
complic
includ
infertil
ectop
pregnanc
chronic
pelvic
pain
clinic
abdomin
pain
abnorm
vagin
bleedingdischarg
dyspareunia
may
mild
nonspecif
find
includ
lower
abdomin
tender
adnex
tender
cervic
motion
tender
index
clinic
suspicion
cervic
swab
urin
naat
chlamydia
gonorrhea
ultrasound
pregnanc
test
ceftriaxon
mg
im
doxycyclin
mg
po
bid
day
levofloxacin
mg
po
daili
day
add
metronidazol
mg
po
bid
day
risk
factor
anaerob
pathogen
inpati
doxycyclin
mg
po
cefoxitin
g
iv
day
clindamycin
mg
iv
gentamicin
mgkg
iv
day
http
wwwphacaspcgccastdmtsstiitscgstildcitsindexengphp
impetigo
follicul
furunculosi
deep
carbuncl
subcutan
abscess
involv
deeper
dermi
subcutan
tissu
cellul
fasciiti
polymicrobi
pyogen
ga
gangren
c
perfringen
compromis
idu
psoriasi
eczema
fungal
diseas
especi
tinea
pedi
compromis
sensorypropriocept
neuropathi
compromis
bloodlymphat
malign
lymphat
venou
insuffici
venectomi
radiat
prior
cellul
spread
infect
involv
dermi
subcutan
tissu
mostli
caus
staphylococci
group
streptococcu
usual
present
swollen
erythemat
plaqu
illdefin
border
cellul
involv
upper
dermi
lymphat
mostli
caus
group
streptococcu
usual
present
rais
erythemat
plaqu
welldemarc
border
occur
commonli
infant
elderli
mrsa
infect
hospit
household
contact
known
mrsa
street
involvedsheltersincarcer
inject
drug
use
athlet
childrenday
care
pyogen
group
streptococcu
aureu
streptococci
b
c
g
f
surgic
aureu
pyogen
human
anaerob
eikenella
corroden
anim
multocida
capnocytophaga
canimorsu
tick
burgdorferi
tularemia
hydrophila
vulnificu
fish
rhusiopathia
streptococcu
inia
hot
aeruginosa
follicul
pain
use
clinic
featur
increas
likelihood
chronic
wound
infect
howev
classic
sign
wound
infect
eg
purul
exud
erythema
heat
edema
use
isol
help
diagnos
chronic
wound
infect
jama
lyte
urea
cr
lactat
suspicion
necrot
fasciiti
portal
entri
open
drain
wound
gram
stain
c
blood
c
indic
system
symptom
drainag
abscess
elev
affect
area
possibl
compress
skin
hydrat
antibiot
mild
cellul
cephalexin
mg
po
qid
dicloxacillin
mg
po
qid
clindamycin
mg
po
qid
day
system
toxic
sever
cellul
cefazolin
g
iv
ceftriaxon
g
iv
nafcillin
g
iv
h
day
mrsa
associ
skin
infect
consid
vancomycin
g
iv
trimethoprimsulfamethoxazol
ds
tab
po
bid
daptomycin
mgkg
iv
daili
tigecyclin
mg
load
dose
mg
iv
doxycyclin
mg
po
bid
linezolid
mg
poiv
mild
erysipela
consid
penicillin
mg
po
qid
amoxicillin
mg
po
tid
sever
erysipela
fever
chill
consid
ceftriaxon
g
iv
cefazolin
g
iv
day
polymicrobi
infect
includ
enterococci
e
coli
nongroup
streptococcu
klebsiella
anaerob
mix
infect
occur
postop
diabet
peripher
vascular
diseas
eg
fournier
gangren
perineum
diabet
type
monomicrobi
streptococcu
pyogen
group
strep
rare
camrsa
may
occur
age
healthi
host
follow
minor
trauma
penetr
injuri
lacer
varicella
idu
childbirth
pathophysiolog
type
ischem
devit
tissu
host
immun
system
antibiot
rel
ineffect
rapid
spread
infect
surround
tissu
late
sign
includ
fever
crepitu
shock
complic
includ
compart
syndrom
acut
renal
failur
sepsi
may
limb
lifethreaten
may
develop
hour
age
cancer
alcohol
immunocompromis
malnutrit
obes
compromis
skin
burn
trauma
postop
infect
compromis
blood
vessel
peripher
vascular
diseas
diabet
clinic
happen
bodi
area
limit
fibrou
tissu
trunk
extrem
pain
disproportion
physic
find
gangren
skin
chang
bulla
tens
edema
crepitu
may
seen
late
sign
index
suspicion
pain
physic
find
plain
xray
check
ga
type
necrot
fasciiti
ct
mri
mayb
use
earli
deep
incision
biopsi
gold
standard
surgic
debrid
necrot
tissu
consid
ivig
signific
hypotens
group
streptococcu
necrot
fasciiti
polymicrobi
g
iv
plu
vancomycin
g
iv
streptococcu
penicillin
g
mu
iv
plu
clindamycin
mg
iv
monomicrobi
aureu
coagulaseneg
staphylococci
gramneg
bacilli
p
aeruginosa
serratia
e
coli
tb
fungi
polymicrobi
aureu
coagulas
neg
staphylococci
pyogen
enterococcu
gramneg
bacilli
anaerob
polymicrobi
aureu
streptococcu
enterococcu
proteu
mirabili
p
aeruginosa
anaerob
monomicrobi
polymicrobi
involv
skin
environment
commens
organ
central
vertebra
sternoclavicular
sacroiliac
sometim
long
bone
femur
tibia
humeru
contigu
spread
soft
tissu
surgeri
orthoped
prosthesi
decubitu
ulcer
contigu
spread
soft
tissu
infect
gener
vascular
ulcer
diabet
ulcer
sickl
cell
diseas
salmonella
compromis
arteri
insuffici
neuropathi
venou
stasi
orthoped
surgeri
probe
bone
ulcer
area
associ
chanc
underli
osteomyel
sen
spc
ppv
npv
noninvas
test
unlik
improv
accuraci
diagnosi
wagner
grade
scale
open
lesion
may
evid
heal
lesion
deform
ulcer
ulcer
tendon
bone
joint
capsul
tissu
involv
abscess
osteomyel
tendin
gangren
toe
forefoot
foot
partial
total
ulcer
area
posit
probetobon
test
result
esr
mmh
abnorm
plain
radiograph
help
diagnos
presenc
lower
extrem
osteomyel
patient
diabet
neg
mri
result
make
diagnosi
much
less
like
find
absent
singl
histor
featur
physic
examin
reliabl
exclud
osteomyel
diagnost
util
combin
find
unknown
gold
standard
diagnosi
bone
biopsi
jama
acut
osteomyel
week
associ
bone
pain
tender
warmth
swell
febril
chill
hip
vertebra
pelvi
tend
manifest
sign
symptom
subacut
osteomyel
week
month
durat
symptom
less
sever
time
drain
sinu
tract
deform
instabl
vascularneurolog
chang
may
develop
chronic
osteomyel
month
subacut
osteomyel
esr
monitor
diseas
progress
elev
urinalysi
c
urin
c
film
specif
insensit
threephas
bone
scan
sensit
ct
mri
sensit
specif
particularli
spine
diabet
foot
indiumlabel
wbc
scan
specif
us
bone
marrow
scan
dual
tracer
scan
ulcer
probe
bone
afb
tb
cultur
fungal
cultur
histolog
gener
requir
vertebr
osteomyel
ctguid
biopsi
provid
microbiolog
diagnosi
guid
therapi
ankl
brachial
ulcer
suspect
tissu
swell
ga
cortic
destruct
periost
new
bone
format
foreign
bodi
deform
fractur
soft
tissu
ga
usual
first
imag
investig
osteomyel
howev
may
detect
chang
week
infect
may
help
make
diagnosi
osteomyel
never
exclud
sen
spc
ppv
diabet
foot
osteomyel
sensit
less
specif
plain
film
sen
spc
diabet
foot
osteomyel
use
rule
osteomyel
make
diagnosi
sensit
specif
still
poor
bone
scan
diabet
foot
sinc
wbc
accumul
marrow
scan
less
sensit
area
red
marrow
vertebra
pelvi
excel
fractur
nonunion
osteomyel
sen
spc
great
anatom
detail
sensit
specif
bone
scan
imag
choic
specif
bodi
site
vertebra
diabet
foot
collect
adjac
bone
without
interven
soft
tissu
elev
periosteum
mm
thicken
periosteum
sensit
specif
uncertain
standard
osteomyel
gener
requir
vertebr
osteomyel
posit
blood
cultur
correspond
radiolog
find
may
support
diagnosi
sometim
replac
bone
biopsi
consid
hold
antibiot
therapi
lifethreaten
infect
facilit
identif
organ
organ
superfici
skin
swab
littl
correl
actual
organ
grow
insid
bone
except
aureu
diabet
mellitu
p
vertebr
osteomyel
need
blood
bone
cultur
start
empir
antibiot
cloxacillin
g
iv
h
cefazolin
g
iv
consid
vancomycin
mgkg
iv
high
local
mrsa
rate
organ
identifi
treat
specif
antibiot
total
week
antibiot
guid
suscept
time
biopsi
definit
surgeri
least
week
iv
therapi
fail
therapi
consid
bonesoft
tissu
debrid
anoth
week
antibiot
definit
surgeri
orthoped
surgeri
specimen
collect
start
vancomycin
mgkg
iv
sternal
osteomyel
give
vancomycin
mgkg
iv
switch
specif
antibiot
total
week
antibiot
time
definit
surgeri
usual
intraven
durat
base
therapi
bone
cultur
empir
coverag
includ
anaerob
eg
carbapenem
result
discspac
seed
hematogen
dissemin
seed
urinari
tract
trauma
extens
infect
adjac
structur
complic
spine
disc
surgeri
risk
factor
includ
extraspin
infect
site
urinari
tract
instrument
vascular
cathet
hemodialysi
intraven
drug
abus
cancer
diabet
mellitu
clinic
back
pain
limit
function
fever
blood
cultur
bone
biopsi
gener
requir
confirm
microbiolog
diagnosi
guid
therapi
g
iv
h
cefazolin
g
iv
consid
vancomycin
mgkg
iv
high
local
mrsa
rate
commonli
due
coagulaseneg
staphylococci
retent
prosthesi
may
possibl
earlyonset
infect
within
month
surgeri
short
durat
symptom
week
sinu
tract
stabl
implant
caus
organ
suscept
quinolon
rifampin
given
month
hip
month
knee
initi
cours
appropri
iv
antibiot
therapi
least
week
debrid
retent
appropri
remov
infect
prosthesi
onestag
twostag
exchang
iv
antibiot
therapi
also
provid
week
follow
initi
surgeri
nejm
see
septic
arthriti
p
mycobacterium
consist
speci
tb
caus
tuberculosi
complex
includ
tuberculosi
bovi
other
cell
envelop
contain
mycol
acid
resist
destain
acid
alcohol
thu
term
acid
fast
bacilli
transmiss
almost
exclus
airborn
inhal
minut
droplet
nuclei
therefor
lung
primari
focu
howev
organ
becom
infect
bacteremia
follow
initi
lung
infect
initi
infect
asymptomat
detect
tuberculin
skin
test
tst
interferongamma
releas
assay
igra
risk
activ
infect
gener
first
year
risk
reactiv
thereaft
world
popul
infect
tb
birth
endem
area
less
commonli
travel
major
risk
factor
risk
factor
includ
aborigin
popul
racialethn
minor
householdinstitut
contact
crowd
healthcar
worker
longterm
care
correct
facil
substanc
abus
shelter
infect
import
risk
factor
alway
test
activ
tb
hiv
fibronodular
diseas
cxr
chronic
renal
failur
increas
age
malign
transplantimmunosuppress
silicosi
chronic
steroid
use
inhibitor
alcohol
abus
malnutrit
liver
kidney
diseas
poorli
control
diabet
smoke
gastrectomi
jejunoil
bypass
night
sweat
pleurit
chest
pain
chronic
cough
anorexia
weight
loss
fatigu
erythema
nodosum
none
primari
tb
usual
involv
mediastin
lymph
node
ghon
complex
hilar
lymphadenopathi
presenc
rml
collaps
common
radiolog
find
pleural
effus
lung
infiltr
may
seen
involv
lower
lung
middl
lung
field
commonli
possibl
cavit
area
consolid
progress
cough
yellowgreen
sputum
increas
time
hemoptysi
chest
paindyspnea
fevernight
sweat
fatigu
weight
loss
tb
usual
involv
apicalposterior
segment
upper
lobe
cavit
hilar
lymphadenopathi
like
cavit
aid
patient
elderli
reactiv
fever
night
sweat
hemoptysi
less
often
lesion
less
often
cavitari
less
often
tst
posit
rare
massiv
pneumothorax
common
endem
countri
bronchiectasi
pulmonari
destruct
rare
tuberculosi
pregnanc
p
lyte
urea
cr
ast
alt
alp
bilirubin
albumin
urinalysi
c
mycobacteri
cultur
sputum
gram
stainafbc
urin
afbc
hiv
serolog
ct
chest
skin
diagnost
issu
detail
interferon
gamma
releas
gold
intub
qftgit
assay
tspot
tb
assay
pcr
molecular
outbreak
suscept
extra
week
effus
send
fluid
afb
tb
cultur
pleural
biopsi
tb
cultur
standard
diagnos
latent
tuberculosi
epidemiolog
tool
sensit
specif
includ
exclud
activ
pulmonari
tb
given
unit
tst
purifi
protein
deriv
intraderm
measur
extent
indur
h
skin
test
reaction
cutoff
correspond
popul
group
test
consid
posit
north
america
follow
gener
consid
neg
treatment
indic
unless
child
year
age
high
risk
tb
posit
recent
infecti
tb
contact
within
year
cxr
sign
fibronodular
diseas
immunosuppress
inhibitor
organ
transplant
glucocorticoid
treatment
equival
mgday
prednison
month
end
stage
renal
other
includ
tst
convers
within
year
diabet
malnutrit
ideal
bodi
weight
cigarett
smoke
daili
alcohol
consumpt
drinksday
silicosi
hematolog
malign
leukemialymphoma
certain
carcinoma
eg
head
neck
lung
canadian
tuberculosi
standard
edit
affect
prior
bcg
vaccin
use
evalu
latent
tb
posit
tst
previous
vaccin
bcg
sputum
day
afb
tb
cultur
induc
sputum
necessari
bronchoscop
lavag
obtain
sputum
three
consecut
afbneg
sputum
sampl
support
patient
noninfecti
come
isol
detect
cultur
posit
tb
nonendem
area
posit
smear
may
repres
nontb
mycobacterium
stain
acid
fast
stain
auramin
fluoresc
stain
improv
sensit
must
confirm
acid
fast
week
egg
media
day
radiometr
sen
spc
pcr
use
nonendem
countri
rule
common
mycobacteria
high
specif
variabl
sensit
afb
posit
sen
spc
afb
posit
sen
spc
mg
po
daili
month
rifampin
mg
po
daili
month
decis
tuberculin
test
decis
treat
age
cutoff
treatment
regardless
bcg
vaccin
statu
exclud
activ
tb
sputum
cultur
cxr
treatment
hiv
immunosuppress
newli
infect
patient
prioriti
treatment
latent
tb
isol
singl
room
neg
air
pressur
tb
therapi
undertaken
consult
expert
suscept
test
necessari
guid
treatment
directli
observ
treatment
dot
standard
care
patient
tb
therapi
consist
intens
phase
daili
therapi
follow
continu
phase
twice
thriceweekli
therapi
rifampin
mgkg
mg
po
daili
isoniazid
mgkg
mg
po
daili
pyrazinamid
mgkg
po
daili
week
ethambutol
mgkg
po
daili
ad
drug
suscept
result
avail
follow
isoniazid
rifampin
daili
twice
weekli
three
time
weekli
week
altern
includ
isoniazid
rifampin
pyrazinamid
plu
ethambutol
streptomycin
three
time
weekli
week
isoniazid
rifampin
pyrazinamid
plu
ethambutol
week
twice
weekli
week
follow
isoniazid
rifampin
twice
weekli
week
see
guidelin
except
altern
regimen
face
resist
drug
intoler
bacillu
calmetteguerin
miliari
mening
tb
pulmonari
tb
children
howev
bcg
lead
falseposit
skin
test
may
compromis
contact
trace
decis
treat
latent
tb
infect
routin
perform
area
low
endem
tb
risk
effect
method
prevent
multidrugresist
tuberculosi
accord
rifampin
rif
side
effect
includ
hepat
toxic
less
inh
induc
hepat
microsom
enzym
clearanc
effect
mani
drug
flulik
symptom
redorang
urin
sweat
tear
isoniazid
inh
inexpens
side
effect
includ
hepat
increas
age
alcohol
use
peripher
neuropathi
pyridoxin
mg
po
daili
mg
po
daili
hiv
diabet
malnourish
renal
failur
pregnanc
breast
feed
pyrazinamid
pza
acid
ph
cell
side
effect
includ
gi
intoler
hepat
injuri
hyperuricemia
due
renal
excret
arthraligia
bacteriostat
main
side
effect
optic
neuriti
cr
ast
alp
bilirubin
uric
acid
pyrazinamid
visual
acuiti
redgreen
color
discrimin
ethambutol
hepatotox
visual
disturb
treatment
outcom
without
hiv
treatment
activ
tb
infect
hiv
patient
extend
beyond
month
bacteriolog
clinic
respons
slow
suboptim
also
bewar
tb
hiv
drug
interact
proteas
inhibitor
nonnucleosid
revers
transcriptas
inhibitor
may
caus
toxic
level
rifampin
replac
rifabutin
coagulas
aureu
coagulas
epidermidi
saprophyticu
homini
lugdunesi
schleiferi
pneumonia
viridian
group
streptococci
pyogen
group
strep
agalactia
group
b
strep
group
c
f
g
strep
faecali
e
faecium
granulicatella
nutrient
variant
strep
leuconostoc
lactococcu
aerococcu
streptococcu
peptococcu
anaerococcu
tuberculosi
lepra
aviumintracellular
complex
nontubercul
mycobacteria
ntm
also
known
mycobacteria
tb
mott
organ
grampositivetyp
cell
wall
stain
gram
posit
due
waxi
mycol
acid
cell
envelop
anthrax
bacillu
cereu
perfringen
c
difficil
c
botulinum
aerob
facult
lactobacillu
listeria
gardenerella
nocardia
propionibacterium
eubacterium
ctinomyc
acid
fast
neg
b
acillu
c
lostridium
diphtheroid
l
isteria
l
actobacillu
ycobacterium
modifi
acid
fast
n
ocardia
modifi
acid
fast
meningitidi
diplococci
n
gonorrhoea
diplococci
neisseria
catarrhali
glucos
ferment
lactos
number
enterobacteriacea
includ
e
coli
citrobact
enterobact
klebsiella
serratia
glucos
ferment
nonlactos
salmonella
hafnia
morganella
proteu
yersinia
edwardsiella
vibrio
oxidas
posit
aeromona
oxidas
posit
pleisiomona
oxidas
posit
nonglucos
nonlactos
ferment
oxidas
ralstonia
burkholderia
roseomona
sphingomona
oxidas
acinetobact
chryseomona
fragili
fusobacterium
prevotella
porphyromona
pasteurella
cat
capnocytophaga
dog
kingella
actinobacillu
cardiobacterium
haemophilu
coccobacilli
pleomorph
legionella
bcye
agar
campylobact
boomerang
hacek
organ
endocard
mycoplasma
ureaplasma
rickettsia
treponema
coxiella
ehrlichia
mycobacteria
clindamycin
develop
resist
penicillin
alter
penicillinbind
protein
develop
resist
penicillin
intrins
mechan
confer
resist
need
treat
dual
antibiot
therapi
seriou
infect
therapi
week
suscept
yet
avail
enterococci
aureu
resist
penicillin
also
penicillinaseresist
penicillin
methicillin
nafcillin
oxacillin
gener
hospit
mrsa
strain
broader
resist
eg
clindamycin
tetracyclin
communityassoci
mrsa
strain
camrsa
risk
factor
hospit
mrsa
infect
includ
frequent
hospit
visit
contact
mrsainfect
individu
camrsa
associ
crowd
acut
chronic
skin
diseas
poor
hygien
share
contamin
item
contact
sport
idu
e
coli
klebsiella
haemophilu
neisseria
bacteroid
induc
aureu
p
p
seudomona
indoleposit
c
e
h
organ
induc
chromosom
mediat
cephalosporinas
ampc
type
resist
penicillin
first
second
gener
cephalosporin
cephamycin
inhibitor
organ
may
extend
spectrum
esbl
resist
except
carbapenem
ototox
neuromuscular
blockad
rare
serum
aminoglycosid
level
correl
nephrotox
indic
mild
infect
uncompl
uti
synergi
gram
posit
infect
give
mgkg
iv
seriou
gramposit
infect
sepsi
give
mgkg
iv
lifethreaten
infect
give
mgkg
iv
mgkg
iv
monitor
serum
level
steadi
state
reach
ie
halfliv
third
dose
monitor
renal
function
ototox
everi
day
peak
min
end
infus
drug
given
synergi
uncompl
infect
seriou
gramneg
infect
sepsi
lifethreaten
infect
trough
min
prior
schedul
dose
prevent
toxic
interv
depend
renal
function
crcl
mlmin
mlmin
mlmin
mlmin
singl
dose
measur
serum
concentr
give
prn
chang
dose
without
chang
interv
result
proport
chang
peak
trough
serum
drug
concentr
prolong
dose
interv
also
reduc
particularli
trough
level
treatment
gramneg
infect
less
nephrotox
dose
similar
ototox
neuromuscular
toxic
infect
outsid
urinari
tract
pregnant
patient
dialysi
patient
endocard
cn
infect
osteomyel
ophthalmolog
infect
surgic
prophylaxi
patient
rapid
drug
clearanc
eg
burn
bsa
gramposit
infect
patient
receiv
concurr
ototoxin
eg
furosemid
neonat
pediatr
patient
signific
renal
dysfunct
durat
therapi
day
mgkg
iv
mgkg
iv
h
serum
level
h
first
dose
monitor
renal
function
ototox
interv
h
base
h
serum
level
hartford
nomogram
antimicrob
agent
chemoth
pharmaci
consult
assist
dose
daili
dose
provid
peak
level
trough
level
prevent
toxic
peak
trough
level
need
monitor
obes
patient
ie
actual
bodi
weight
bw
ideal
bodi
weight
ibw
use
adjust
bodi
weight
abw
dose
determin
abw
kg
ibw
bwibw
note
kg
lb
see
p
ibw
calcul
drug
erupt
p
infusionrel
red
man
syndrom
rare
nephrotox
especi
combin
aminoglycosid
ototox
howev
serum
vancomycin
level
predict
toxic
mgkg
usual
g
iv
mgkg
actual
bodi
weight
per
day
divid
dose
maximum
usual
gdose
steadi
state
ie
third
dose
normal
second
dose
dose
interv
h
monitor
treatment
durat
day
patient
stabl
renal
function
mildmoder
infect
treatment
durat
day
patient
unstabl
renal
function
sever
infect
trough
min
next
schedul
dose
least
adjust
seriou
infect
endocard
osteomyel
peak
correl
efficaci
toxic
therefor
monitor
interv
depend
renal
function
crcl
mlmin
mlmin
mlmin
mlmin
mlmin
mlmin
singl
dose
measur
serum
concentr
give
prn
chang
dose
without
chang
interv
result
proport
chang
peak
trough
serum
drug
concentr
prolong
dose
interv
also
reduc
particularli
trough
level
reaction
age
reaction
occur
time
reaction
penicillin
administr
type
reaction
rout
administr
reason
penicillin
medic
time
resolut
similar
antibiot
sinc
crossreact
cephalosporin
patient
penicillin
allergi
histori
carbapenem
firstsecondgener
cephalosporin
higher
crossreact
penicillin
allerg
thirdgener
cephalosporin
aztreonam
often
safe
use
medic
first
dose
monitor
safeti
unclear
skin
test
provid
reassur
patient
histori
penicillin
allergi
posit
neg
skin
test
chanc
develop
crossreact
cephalosporin
respect
nejm
penicillin
allergi
predict
posit
respons
penicillin
skin
test
result
lr
predict
allerg
respons
anaphylaxi
posit
skin
test
respons
second
cours
penicillin
lr
type
allerg
reaction
antibodymedi
ige
cytotox
antibodydepend
immunecomplexmedi
delay
hypersensit
reaction
type
h
ige
antibodi
mediat
anaphylaxi
hypotens
laryng
edema
wheez
angioedema
urticaria
type
h
igg
complement
mediat
increas
clearanc
rbc
platelet
lymphoreticular
system
type
h
igg
igm
immun
complex
mediat
serum
sick
tissu
injuri
type
h
contact
dermat
h
maculopapular
morbilliform
rash
patient
report
histori
penicillin
allergi
truli
allerg
assess
skin
test
take
detail
histori
patient
reaction
penicillin
may
allow
clinician
exclud
true
penicillin
allergi
allow
patient
receiv
penicillin
patient
concern
histori
type
penicillin
allergi
compel
need
drug
contain
penicillin
undergo
skin
test
virtual
patient
neg
skin
test
result
take
penicillin
without
seriou
sequela
jama
neg
skin
test
result
may
still
react
repeat
cours
penicillin
likelihood
lifethreaten
reaction
greatli
reduc
patient
welldocu
immedi
reaction
penicillin
like
react
subsequ
cours
ration
clinic
examin
mcgrawhil
like
deadli
organ
type
infect
thu
good
understand
pathophysiolog
infect
local
resist
pattern
variou
organ
essenti
alway
perform
facilit
target
antibiot
treatment
except
mild
infect
howev
specif
organ
may
identifi
even
multipl
cultur
taken
case
clinician
must
reli
clinic
judgment
continu
treatment
empir
antibiot
suspect
sourc
pulmonari
sourc
respiratori
fluoroquinolon
plu
ceftriaxon
vancomycin
commun
set
antipseudomon
plu
ciprofloxacin
hospit
set
urinari
sourc
ceftriaxon
carbapenem
fluoroquinolon
aminoglycosid
intraabdomin
sourc
carbapenem
durat
treatment
least
day
ration
antibiot
suscept
result
avail
see
p
detail
ampicillin
vancomycin
add
acyclovir
csf
suggest
viral
pictur
durat
treatment
day
see
p
detail
cefotaxim
respiratori
fluoroquinolon
durat
treatment
usual
day
see
p
detail
plu
metronidazol
durat
treatment
usual
least
day
see
p
detail
plu
ceftazidim
carbapenem
durat
treatment
usual
day
p
durat
treatment
highli
variabl
see
aha
guidelin
p
detail
nativ
valv
cloxacillinnafcillin
vancomycin
plu
gentamicin
inject
drug
vancomycin
plu
gentamicin
prosthet
valv
plu
gentamicin
durat
treatment
day
see
p
detail
metronidazol
durat
treatment
day
see
p
detail
imipenem
ampicillin
plu
ciprofloxacin
plu
metronidazol
treat
wbcperiton
resolv
durat
treatment
usual
day
see
p
inform
ciprofloxacin
fosfomycin
durat
treatment
day
uncompl
uti
otherwis
day
see
p
detail
cloxacillin
cephalexin
vancomycin
mrsa
suspect
durat
treatment
usual
day
see
p
detail
clindamycin
plu
ciprofloxacin
ciprofloxacin
plu
clindamycin
plu
metronidazol
treat
resolut
may
requir
iv
antibiot
pseudomona
coverag
eg
carbapenem
osteomyel
like
ulcer
probe
touch
bone
see
p
detail
treatment
mandatori
polymicrobi
infect
cefotaxim
plu
clindamycin
ampicillinpenicillin
g
plu
ciprofloxacingentamicin
plu
metronidazol
streptococcu
penicillin
g
plu
clindamycin
see
p
detail
gramposit
coverag
cefazolin
vancomycin
gramneg
coverag
ceftriaxon
ciprofloxacin
pseudomona
piperacillin
carbapenem
ceftazidim
plu
ciprofloxacin
aminoglycosid
durat
therapi
usual
least
week
see
p
detail
cloxacillin
cefazolin
gramposit
coverag
ciprofloxacin
ceftriaxon
gramneg
coverag
usual
durat
week
see
p
detail
see
hepat
b
p
see
hepat
c
p
see
herp
simplex
viru
p
transfus
unsaf
needl
use
develop
world
health
worker
deliveri
breast
feed
global
mainli
west
africa
febril
mononucleosislik
ill
lymphadenopathi
pharyng
rash
headach
within
week
postexposur
hematolog
lymphopenia
thrombocytopenia
liver
enzym
abnorm
assay
sen
spc
posit
repeat
elisa
posit
western
blot
indetermin
repeat
western
blot
week
month
month
later
window
period
week
postexposur
may
perform
viral
load
test
hiv
load
count
genotyp
antiretrovir
drug
resist
test
lyte
urea
cr
ast
alt
alp
bilirubin
tsh
glucos
fast
lipid
profil
lipas
ck
hla
b
abacavir
hypersensit
cxr
ecg
urinanalysi
coexistingopportunist
serolog
hbv
test
hbsag
hbsab
hbcab
hbsag
hbcab
posit
check
hbv
dna
well
hcv
test
hcv
antibodi
hcv
posit
hcv
rna
assess
genotyp
order
fibroscan
pap
smear
anal
screen
hpv
men
sex
men
msm
consensu
yet
chlamydia
gonorrhea
screen
syphili
test
tst
igra
toxoplasma
serolog
cmv
serolog
progress
speed
train
indic
activ
viral
replic
critic
measur
effect
antiretrovir
therapi
start
stage
diseas
distanc
crash
indic
rel
health
immun
system
risk
opportunist
complic
load
count
usual
interv
week
chang
haart
aidsdefin
diseas
tb
recurr
salmonella
sepsi
retin
chronic
hsv
pml
candidiasi
extrapulmonari
coccidioidomycosi
histoplasmosi
cryptococcosi
jiroveci
pneumonia
pjp
toxoplasmosi
chronic
cryptosporidiosi
isosporiasi
encephalopathi
wast
syndrom
sarcoma
cn
lymphoma
nonhodgkin
lymphoma
cervic
carcinoma
liver
diseas
cardiovascular
diseas
nonaid
cancer
brain
usual
multipl
ringenhanc
lesion
tuberculosi
cryptococcu
histoplasma
aspergillosi
cn
lymphoma
progress
multifoc
leukoencephalopathi
pml
jc
viru
hypodens
white
matter
lesion
lyte
urea
cr
blood
c
toxoplasma
igg
antibodi
ebv
pcr
jc
viru
pcr
ctmr
head
pet
scan
cn
lymphoma
higher
activ
abscess
brain
biopsi
suspect
cn
lymphoma
combin
multipl
ring
enhanc
lesion
posit
antitoxoplasmosi
antibodi
lack
toxoplasma
prophylaxi
hiv
patient
count
ppv
diagnos
toxoplasma
plu
either
sulfadiazin
clindamycin
cryptococcu
fungu
high
open
pressur
bacteri
mening
mening
pneumonia
listeria
gramneg
bacilli
viral
mening
enceph
lyte
urea
cr
blood
c
serum
crag
sen
cryptococcu
ct
head
lumbar
punctur
cryptococcu
cryptoantigen
amphotericin
b
mgkg
iv
daili
plu
flucytosin
mgkg
po
qid
switch
fluconazol
mg
po
daili
month
consolid
follow
fluconazol
mg
po
daili
mainten
manag
increas
intracrani
pressur
may
need
neuroimag
rule
concomit
spaceoccupi
lesion
repeat
lp
decreas
icp
communityacquir
pneumonia
common
caus
pneumonia
other
includ
moraxella
h
influenza
tuberculosi
increas
risk
hiv
patient
may
extrapulmonari
nontb
pulmonari
involv
alon
rare
usual
dissemin
fungal
coccidioid
cryptococcu
pneumocysti
jirovecii
pneumonia
pjp
lyte
urea
cr
ldh
pjp
nonspecif
blood
c
mycobacteri
cultur
sputum
c
afb
abg
aa
gradient
urin
c
cxr
bronchoscopi
lavag
biopsi
mg
tmpkg
poiv
divid
daili
day
sever
diseas
mmhg
aa
gradient
mmhg
room
air
add
prednison
mg
po
bid
day
mg
po
daili
day
mg
po
daili
day
altern
includ
dapson
plu
trimethoprim
clindamycin
plu
primaquin
pentamidin
iv
use
atovaquon
defici
infect
candida
hsv
cmv
pill
esophag
neoplasm
idiopath
therapi
fluconazol
endoscopi
cultur
fungu
viru
biopsi
infect
tb
mycobacterium
avium
complex
mac
avium
intracellular
hcv
cmv
microsporidium
cyclospora
alcohol
antibiot
sulfa
isoniazid
rifampin
ketoconazol
fluconazol
lyte
urea
cr
ast
alt
alp
bilirubin
lipas
inr
cultur
serolog
us
abd
ct
abd
ercp
infect
shigella
campylobact
yersinia
ehec
eiec
c
difficil
tb
mycobacterium
avium
complex
mac
avium
intracellular
cmv
parasit
entamoeba
giardia
isospora
cryptosporidium
antibiot
aid
exclus
lyte
urea
cr
stool
c
stool
p
acid
fast
stain
stool
mac
c
diff
toxin
fecal
wbc
cryptosporidium
microsporidium
mg
po
bid
azithromycin
mg
po
daili
plu
ethambutol
mgkg
po
daili
plu
rifabutin
mg
po
daili
least
month
least
month
immun
reconstitut
k
aposi
sarcoma
associ
lesion
may
involv
skin
oral
mucosa
lung
gi
tract
treat
liposom
doxorubicin
lesion
may
also
resolv
antiretrovir
treatment
nonh
odgkin
lymphoma
larg
bcell
lymphoma
primari
effus
lymphoma
associ
ebv
plasmablast
lymphoma
treat
combin
chemotherapi
chopr
primari
cn
lymphoma
associ
ebv
treat
radiat
andor
highdos
methotrex
intrathec
chemotherapi
cervic
carcinoma
associ
hpv
treat
surgeri
radiat
andor
chemotherapi
cisplatin
incid
hodgkin
lymphoma
multipl
myeloma
anogenit
cancer
testicular
cancer
seminoma
basal
cell
carcinoma
hiv
patient
lung
cancer
colorect
cancer
melanoma
squamou
cell
carcinoma
skin
head
neck
cancer
may
also
increas
must
told
reveal
hiv
statu
sexual
partner
report
diseas
advis
regard
condom
use
safer
sex
practic
risk
reduct
strategi
explor
substanc
abus
eg
avoid
share
needl
drug
paraphenalia
tobacco
use
social
issu
hiv
chronic
diseas
success
treat
patient
ss
tab
po
daili
ds
tab
po
daili
ds
tab
po
three
time
week
allerg
desensit
use
dapson
inhal
pentamidin
patient
posit
toxoplasma
serolog
ds
tab
po
daili
allerg
dapson
plu
pyrimethamin
plu
folin
acid
altern
patient
azithromycin
mg
po
weekli
patient
live
endem
area
itraconazol
mg
po
daili
patient
posit
tst
reaction
indur
mm
treat
tb
previous
isoniazid
mgkgday
po
daili
max
mgday
mg
thrice
weekli
month
rifampin
mg
po
daili
month
restrict
exposur
inhresist
rifsuscept
isol
follow
tb
specialist
follow
pneumococc
polysaccharid
vaccin
least
week
later
pnemococc
vaccin
repeat
everi
year
three
dose
hepat
b
vaccin
nonimmun
hepat
vaccin
nonimmun
especi
homosexu
influenza
vaccin
annual
recommend
gener
vaccin
oral
polio
varicella
measlesmumpsrubella
yellow
fever
immun
count
hepat
b
p
hepat
c
p
hiv
pregnanc
p
needl
stick
injuri
p
tuberculosi
p
zdv
azt
stavudin
didanosin
ddi
lamivudin
abacavir
abc
tenofovir
tdf
emtricitabin
ftc
major
side
effect
includ
hepat
steatosi
lactic
acidosi
neuropathi
anemia
pancreat
renal
diseas
efv
nevirapin
nvp
etravirin
etr
rilpivarin
rpv
major
side
effect
includ
rash
syndrom
hepat
cn
complic
sqv
indinavir
idv
nelfinavir
nfv
lpvrtv
fosamprenavir
fpv
atazanavir
atv
tipranavir
tpv
darunavir
drv
major
side
effect
includ
hyperglycemia
fat
redistribut
syndrom
insulin
resist
gi
intoler
dolutegravir
elvitegravir
nrti
tenofovir
plu
emtricitabin
plu
nnrti
efavirenz
nrti
tenofovir
plu
emtricitabin
plu
pi
atazanavirritonavir
darunavirritonavir
nrti
tenofovir
plu
emtricitabin
plu
integras
inhibitor
suppress
hiv
viral
load
undetect
level
reduct
hiv
relat
morbid
improv
qualiti
life
prolong
surviv
restor
immun
function
prevent
hiv
transmiss
treatment
symptomat
patient
asymptomat
patient
treatment
consid
patient
rapidli
declin
count
baselin
viral
load
copiesml
increas
urgenc
treatment
initi
hiv
treatment
regardless
pregnanc
hiv
nephropathi
hbv
therapi
hbv
indic
commit
lifelong
treatment
adher
essenti
prior
initi
therapi
hiv
therapi
increasingli
complex
undertaken
expertis
hiv
manag
viral
load
log
week
copiesml
month
therapi
need
continu
therapi
may
develop
viral
load
rebounddrug
resist
failur
consid
nonadher
andor
resist
resist
test
perform
regimen
chang
base
resist
profil
week
sever
month
inflammatori
respons
immun
system
restor
antiretrovir
lead
acut
paradox
deterior
preexist
infect
tb
mac
pjp
histoplasma
hcv
hbv
clinic
featur
highli
variabl
iri
diagnosi
exclus
consid
drug
reaction
nonadher
new
onset
progress
opportunist
infect
may
occur
patient
opportunist
infect
start
haart
eg
lymphadenopathi
start
antiretrovir
patient
dissemin
mac
worsen
cxr
fever
patient
tb
gener
treat
opportunist
infect
week
prior
initi
antiretrovir
therapi
continu
antiretrovir
give
corticosteroid
coinfect
rate
asiasubsaharan
africa
transmiss
mostli
vertic
young
children
usa
europ
transmiss
mostli
via
idu
sexual
contact
coinfect
associ
increas
risk
progress
endstag
liver
diseas
patient
isol
hbcab
occult
hbv
infect
detect
level
hbv
dna
b
vaccin
famili
sexual
partner
combin
therapi
nucleosid
analogu
nucleotid
analogu
eg
tenofovir
plu
either
emtricitabin
lamivudin
recommend
coinfect
patient
ultrasound
afp
recommend
everi
month
hepatocellular
carcinoma
screen
coinfect
rate
patient
idu
hemophilia
msm
coinfect
result
aggress
hcv
rapid
progress
liver
failur
hepatocellular
carcinoma
particularli
concurr
alcohol
use
may
hcv
seroneg
requir
pcr
test
histolog
injuri
defin
liver
biopsi
fibroscan
much
better
predictor
clinic
outcom
liver
enzym
hcv
viral
load
may
use
select
patient
guid
therapi
reduct
safer
needl
use
hcv
rapidli
chang
new
directli
act
agent
replac
interferon
ribavirin
drug
choic
treatment
hcv
increas
rate
cure
fewer
side
effect
see
chapter
hepat
c
detail
p
abc
parainfluenza
rsv
metapneumoviru
adenoviru
rhinoviru
pneumonia
staphylococcu
aureu
haemophilu
moraxella
chlamydia
legionella
tb
communityacquir
mrsa
three
type
influenza
b
c
influenza
classifi
variou
subtyp
base
combin
two
surfac
glycoprotein
neuraminidas
subtyp
hemagglutinin
subtyp
eg
influenza
subtyp
influenza
b
classifi
variou
strain
aris
due
antigen
drift
b
influenza
c
virus
mainli
affect
human
contrast
influenza
infect
human
anim
includ
wild
bird
poultri
pig
dog
hors
influenza
strain
highli
pathogen
caus
sever
diseas
specif
host
other
associ
low
pathogen
process
wherebi
least
two
differ
viral
strain
combin
form
new
subtyp
mixtur
surfac
antigen
origin
strain
term
antigen
shift
sourc
pandem
influenza
viru
gradual
chang
viral
rna
sequenc
occur
influenza
b
process
due
random
point
mutat
gene
encod
neuraminidas
hemagglutinin
creat
strain
viru
new
surfac
glycoprotein
thu
antibodi
previou
strain
ineffect
result
season
epidem
abrupt
signific
emerg
novel
viral
strain
happen
influenza
antigen
shift
occur
mix
human
influenza
anim
eg
pig
bird
influenza
viru
gene
creat
new
human
influenza
subtyp
process
call
genet
reassort
eg
swine
flu
avian
flu
rare
avian
strain
influenza
may
directli
infect
human
antigen
shift
gener
new
viru
trigger
pandem
major
popul
immun
new
viru
worldwid
outbreak
follow
criteria
emerg
new
subtyp
influenza
viru
viru
abl
infect
human
viru
spread
easili
person
person
sustain
manner
onset
system
symptom
fever
headach
myalgia
arthralgia
fatigu
respiratori
symptom
cough
dyspnea
sore
throat
bacteri
pneumonia
muscular
rhabdomyolysi
myositi
neurolog
enceph
asept
mening
transvers
myeliti
syndrom
clinic
find
identifi
patient
influenzalik
ill
particularli
use
confirm
exclud
diagnosi
influenza
clinician
use
time
epidemiolog
data
ascertain
influenza
circul
commun
either
treat
patient
influenzalik
ill
empir
obtain
rapid
influenza
test
assist
manag
decis
jama
lyte
urea
cr
ast
alt
alp
bilirubin
urinalysi
swab
rapid
assay
variabl
sensitivityspecif
rtpcr
prefer
dfa
direct
fluoresc
antigen
detect
blood
c
sputum
gram
stainafbc
urin
c
lumbar
neurolog
symptom
abg
vaccin
follow
individu
older
children
month
take
longterm
salicyl
chronic
medic
condit
pregnant
women
healthcar
worker
household
contact
risk
resid
chronic
care
facil
jurisdict
univers
vaccin
influenza
recommend
depend
match
vaccin
circul
viru
efficaci
rang
good
match
poor
match
inhibitor
oseltamivir
mg
po
bid
day
zanamivir
mg
inhal
bid
day
activ
influenza
b
antivir
treatment
effect
start
within
h
symptom
onset
treatment
decreas
durat
symptom
day
reduc
viral
shed
may
reduc
complic
risk
inhal
zanamivir
rel
contraind
patient
asthma
chronic
respiratori
condit
household
contact
infect
individu
vaccin
may
given
prophylaxi
oseltamivir
mg
po
daili
zanamivir
mg
inhal
daili
day
resist
oseltamivir
problem
strain
influenza
amantadin
rimantidin
may
role
treatment
secondari
bacteri
pneumonia
antibiot
play
import
role
viral
releas
host
cell
oral
oseltamivir
inhal
zanamivir
activ
influenza
influenza
b
replic
influenza
rna
inhibit
protein
ion
channel
amantadin
rimantadin
inact
influenza
b
c
resist
widspread
influenza
februarymarch
world
health
organ
make
recommend
regard
three
strain
two
one
b
influenza
virus
like
caus
outbreak
fallwint
upcom
season
vaccin
produc
base
decis
infect
classifi
three
main
categori
yeast
mold
filament
fungi
dimorph
fungi
singl
cell
via
bud
includ
candida
malassezia
rodotorula
trichosporon
filament
fungi
grow
hypha
via
sexual
asexu
reproduct
includ
aspergillu
zygomycet
fusarium
dematiac
pigment
fungi
ubiquit
environ
eg
soil
decay
veget
water
air
infect
may
caus
blood
vessel
invas
thrombosi
obstruct
clinic
syndrom
includ
cerebr
parenchym
infect
pulmonari
parenchym
infect
hepatosplen
abscess
otiti
externa
dimorph
mold
yeast
includ
coccidioid
histoplasma
blastomyc
cryptococcu
low
temperatur
found
multicellular
mold
releas
spore
inhal
warm
temperatur
eg
insid
bodi
inhal
spore
germin
yeast
infecti
patient
longer
contagi
ie
patient
requir
isol
albican
germtub
posit
pseudohypha
nonalbican
speci
germtub
neg
eg
c
glabrata
c
tropicali
c
parapsilosi
c
krusei
mostli
patient
hematolog
malign
neutropenia
immunosuppress
idu
intens
care
unit
hemodialysi
broadspectrum
antibiot
surgeri
central
venou
cathet
parenter
nutrit
mucocutan
infect
thrush
vagin
seriou
focal
infect
endophthalm
mening
osteomyel
dissemin
infect
candidemia
pustular
skin
lesion
retin
lesion
candiduria
common
icu
patient
usual
repres
colon
unless
patient
symptomat
troch
mg
daili
nystatin
suspens
u
nystatin
pastil
u
daili
fluconazol
mg
poiv
daili
week
mg
load
dose
mg
poiv
daili
week
cathet
indic
treatment
includ
kidney
transplant
recipi
prior
cystoscopi
invas
gu
procedur
neonat
sever
ill
possibl
neutropenia
controversi
fluconazol
mg
poiv
daili
week
acut
dissemin
intravascular
devic
fluconazol
mg
iv
load
dose
mg
poiv
daili
week
minimum
one
echinocandin
includ
caspofungin
mg
mg
iv
daili
micafungin
mg
iv
daili
anidulafungin
mg
load
mg
iv
daili
week
minimum
last
posit
cultur
c
albican
echinocandin
lipid
formul
amphotericin
b
prefer
initi
therapi
neutropen
patient
almost
c
albican
sensit
fluconazol
laboratori
report
c
albican
c
albican
complex
structur
resembl
albican
dubliniensi
clinic
signific
albican
dubliniensi
suscept
pattern
suscept
pattern
nonalbican
infect
may
significantli
differ
consid
echinocandin
nonalbican
candidiasi
cid
contain
speci
includ
fumigatu
clinic
infect
flavu
niger
terreu
patient
neutropenia
organ
stem
cell
transplant
advanc
aid
corticosteroid
invas
aspergillosi
mortal
pulmonari
involv
includ
colon
pulmonari
aspergilloma
fungal
ball
allerg
bronchopulmonari
aspergillosi
abpa
chronic
necrot
aspergillu
pneumonia
cnpa
invas
aspergillosi
second
common
caus
fungal
endocard
candida
cutan
involv
may
follow
trauma
dissemin
respiratori
tract
difficult
may
requir
biopsi
cultur
histolog
check
quantit
immunoglobulin
aspergillu
igg
ige
galactomannan
level
suggest
invas
aspergillosi
ct
chest
may
show
multipl
nodular
lesion
halo
sign
nodul
surround
hemorrhag
air
crescent
sign
necrosi
cavit
sputum
fungal
cultur
eosinophil
bronchoalveolar
lavag
lung
biopsi
galactomannan
assay
rel
specif
invas
aspergillosi
right
clinic
context
provid
adequ
evid
invas
pulmonari
diseas
assay
done
serum
bal
specimen
mgkg
h
mgkg
iv
mg
po
bid
resolv
altern
includ
caspofungin
mg
mg
iv
lipidformul
amphotericin
b
mgkg
iv
daili
micafungin
mg
iv
daili
posaconazol
mg
po
qid
mg
bid
clinic
stabil
speci
especi
terreu
resist
amphotericin
aspergillu
filament
fungu
treat
echinocandin
cid
clin
infect
di
j
clin
microbiol
group
filament
fungi
includ
rhizopu
absidia
rhizomucor
mucor
cunninghamella
affect
immunocompromis
patient
diabet
prognosi
extrem
poor
pulmonari
gi
cutan
involv
infect
caus
devast
rhinoorbitalcerebr
pulmonari
infect
therapi
frequent
need
combin
surgic
debrid
empir
treatment
option
includ
lipid
formul
amphotericin
b
pozaconazol
note
suscept
test
zygomycet
alway
reliabl
caspofungin
azol
apart
pozaconazol
gener
effect
capsulatum
endem
along
st
lawrenc
seaway
midwestern
state
locat
along
ohio
mississippi
river
valley
symptom
typic
occur
patient
immunocompromis
expos
larg
inoculum
asymptomat
pulmonari
manifest
may
mimic
sarcoidosi
includ
pneumonia
local
diffus
granulomacavitari
lung
lesion
hilar
mediastin
lymphadenopathi
pericard
arthriti
arthralgia
erythema
nodosum
may
also
occur
without
pulmonari
symptom
dissemin
diseas
may
present
hepatosplenomegali
pancytopenia
oropharyng
ulcer
skin
cn
involv
cultur
blood
tissu
urin
antigen
histoplasma
serolog
histopatholog
histoplasma
predominantli
intracellular
pathogen
therefor
cultur
need
place
isol
tube
contain
cell
lysi
product
mg
po
tid
day
mg
po
lipid
formul
amphotericin
b
prefer
ill
patient
cid
believ
unicellular
yeast
although
confirm
dimorph
unlik
dimorph
fungi
eg
histoplasma
blastomyc
coccidioid
cryptococcu
ubiquit
geograph
isol
cryptococcu
neoforman
two
varieti
c
neoforman
var
neoforman
var
gattii
c
invari
immunocompromis
patient
includ
hiv
transplant
hematolog
malign
chronic
kidney
diseas
diabet
mellitu
cirrhosi
corticosteroid
use
pathogen
inhal
dissemin
predilect
cn
mening
common
focal
parenchym
infect
c
commonli
immunocompet
host
paradox
uncommon
immunosuppress
host
symptomat
infect
usual
pulmonari
focal
parenchym
brain
infect
pulmonari
cutan
involv
may
involv
organ
infect
lumbar
punctur
lower
intracrani
pressur
amphotericin
b
plu
flucytosin
follow
fluconazol
pulmonari
cutan
infect
fluconazol
itraconazol
cid
lower
desert
southern
arizona
central
california
southwestern
new
mexico
west
texa
usa
also
mexico
central
south
america
peak
incid
affect
mostli
patient
immunosuppress
acut
pulmonari
infect
often
asymptomat
caus
flulik
ill
pneumonia
pulmonari
symptom
includ
chest
pain
cough
fever
hemoptysi
cavitari
lesion
radiolog
unilater
infiltr
hilar
adenopathi
common
cutan
symptom
includ
erythema
nodosum
erythema
multiform
common
site
dissemin
skin
bone
mening
cultur
serolog
note
cocciodioid
level
pathogen
therefor
cultur
process
highlevel
isol
unit
label
care
numer
report
iatrogen
infect
laboratori
personnel
adequ
precaut
taken
resolv
spontan
uncompl
diseas
antifung
therapi
may
need
combin
surgeri
certain
pulmonari
infect
fluconazol
mg
po
daili
itraconazol
mg
po
daili
durat
depend
site
infect
may
last
month
year
coccidioid
mening
treat
amphotericin
b
cid
found
northwest
ontario
great
lake
eastern
state
eg
ohio
mississippi
river
valley
infect
occur
inhal
aerosol
spore
soil
infect
common
pulmonari
symptom
acut
chronic
pneumonia
incub
time
day
extrapulmonari
dissemin
skin
bonejoint
gu
tract
usual
associ
pulmonari
diseas
cultur
presenc
broadbas
bud
yeast
clinic
specimen
strongli
suggest
blastomyc
b
lipid
formul
moder
sever
diseas
cn
involv
itraconazol
mild
diseas
stepdown
poor
barrier
penetr
altern
voriconazol
fluconazol
cid
line
treatment
invas
cn
third
line
treatment
patient
refractori
intoler
fluconazol
first
line
treatment
fungi
yet
speciat
neither
amphotericin
b
fluconazol
use
antifung
treatment
patient
suspect
aspergillu
infect
line
treatment
patient
refractori
intoler
voriconazol
first
line
amphotericin
b
second
line
line
treatment
patient
refractori
intoler
fluconazol
first
line
treatment
fungi
yet
speciat
neither
amphotericin
b
fluconazol
use
antifung
treatment
posit
cultur
lack
clinic
respons
despit
day
therapi
remov
cathet
applic
creatinin
doubl
baselin
mgdl
tripl
serum
creatinin
baselin
creatinin
clearanc
mlmin
concomit
administr
nephrotoxin
document
allergi
intoler
infus
reaction
acquir
hospit
occur
h
admiss
h
discharg
day
surgic
procedur
urinari
cathet
infect
rate
longterm
catheter
complic
includ
cystiti
prostat
pyelonephr
urosepsi
mechan
ventil
h
p
central
venou
cathet
infect
rate
incis
wash
hand
wash
hand
wash
educ
isol
surveil
import
practic
routinestandardunivers
precaut
use
glove
handl
bodi
fluid
except
sweat
alway
use
steril
techniqu
insert
urinari
central
venou
cathet
minim
ng
tube
insert
keep
patient
head
bed
intub
airborn
neg
pressur
room
higheffici
particul
aerat
filter
certifi
respir
person
protect
tuberculosi
measl
neg
pressur
room
requir
droplet
mask
within
ft
eye
protect
influenza
n
meningitidi
influenza
rsv
pertussi
parainfluenza
adenoviru
human
metapneumoviru
respiratori
virus
contact
glove
gown
wash
hand
difficil
vre
mrsa
carbapenemresist
organ
cro
esbl
exposur
last
day
ciprofloxacin
mg
po
dose
rifampin
mg
po
bid
day
use
reduc
risk
n
meningitidi
close
contact
vaccin
recommend
primari
prophylaxi
postexposur
may
use
epidem
control
popul
basi
close
healthcar
worker
direct
exposur
respiratori
secret
eg
mouthtomouth
resuscit
intub
household
member
intim
contact
children
school
environ
cowork
offic
young
adult
dormitori
recruit
train
center
recommend
medic
personnel
ie
without
direct
exposur
patient
oral
secret
casual
indirect
contact
eg
school
workmat
precaut
glove
gown
mask
risk
exposur
bodi
fluid
never
recap
needl
educ
hepat
b
vaccin
month
mechan
exposur
sourc
patient
characterist
pre
postexposur
prophylaxi
sourc
posit
transmiss
via
urin
fece
saliva
unlik
sourc
posit
transmiss
via
urin
fece
unlik
sourc
posit
transmiss
via
urin
fece
saliva
unlik
sourc
patient
hcv
hiv
expos
person
baselin
hcv
hiv
elisa
western
cbcd
lyte
urea
cr
ast
alt
alp
bili
hbv
ig
sourc
patient
hbsag
posit
unknown
expos
person
unvaccin
start
vaccin
hbv
hiv
therapi
day
sourc
patient
hiv
posit
sourc
patient
unknown
high
risk
therapi
may
includ
raltegravir
truvada
tenofoviremtricitabin
sourc
patient
arv
resist
test
known
postexposur
procedur
tailor
accordingli
treatment
start
within
h
sexual
intercours
hold
blood
donat
breastfeed
side
effect
prophylact
medic
followup
week
http
diphtheria
penicillin
erythromycin
pertussi
erythromycin
rabi
rabi
immun
globulin
vaccin
varicella
zoster
varicellazost
immun
globulin
vaccin
hepat
immun
globulin
vaccin
contactssexu
partner
hepat
patient
idu
homosexu
multipl
sexual
partner
tattoo
pierc
transfus
healthcar
worker
prior
vaccin
era
residentswork
institut
mental
ill
crimin
birth
endem
countri
partner
controversi
idu
tattoo
pierc
transfus
residentswork
institut
mental
ill
crimin
pneumococc
meningococc
haemophilu
sever
ill
live
immunocompromis
steroid
aid
hiv
malign
erythema
fever
